Cellceutix files pre-IND papers for psoriasis drug ModernMedicine Biopharmaceutical firm Cellceutix Corp. has filed type A pre-IND (investigational new drug) submission with the substance and Drug Administration connected Prurisol (KM-133), which the company is developing As a treatment for disease of the skin . The submission provides the FDA ... Link To Article
No comments:
Post a Comment